Skip to main content
NVDA-0.40%AAPL-1.61%GOOGL+1.66%MSFT+2.37%AMZN+2.86%TSM-1.61%SPCX+1.21%META+0.72%AVGO+0.73%TSLA+2.34%SKHY-0.25%MU-0.71%BRK-B+0.79%LLY+0.52%AMD-1.67%JPM+0.48%WMT+0.51%V+2.61%XOM+0.54%ASMLa-1.84%JNJ+1.82%INTC-1.47%MA+2.14%0700.HK+3.26%ABBV+1.77%CSCO+2.28%1398.HK-0.92%CVX+0.61%COST-0.50%AMAT-0.02%AP2d-2.02%ORCL+4.61%LRCX-0.20%DELL+0.71%BAC+0.85%KO+0.44%CAT+0.50%PG+0.26%UNH+1.79%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.26%PM+0.08%0857.HK0.00%0939.HK+0.83%NFLX-1.08%MS+1.07%1288.HK-1.52%NZDMXN+1.53%USDMXN+1.47%EURAUD-0.85%AUDJPY+0.65%AUDCHF+0.58%EURUSD-0.55%EURZAR-0.54%USDPLN+0.51%CHFSEK+0.49%AUDCAD+0.48%EURGBP-0.46%USDTRY+0.44%AUDDKK+0.43%GBPAUD-0.43%AUDNZD+0.42%EURNZD-0.42%GBPTRY+0.41%EURCAD-0.37%EURCHF-0.37%GBPZAR-0.36%USDZAR-0.35%EURCNH-0.34%AUDNOK+0.33%USDSEK+0.33%GBPHKD+0.32%EURPLN+0.32%AUDUSD+0.31%AUDSGD+0.31%USDJPY+0.31%GBPMXN-0.28%EURJPY-0.27%CHFNOK+0.24%PLNJPY-0.23%CHFSGD+0.22%SGDJPY+0.22%GBPJPY+0.20%USDCHF+0.19%EURHKD-0.19%NOKJPY+0.19%USDDKK+0.19%NZDJPY+0.19%USDCAD+0.18%USDILS+0.16%USDCNH-0.16%EURSEK+0.14%EURSGD-0.13%NZDSGD+0.12%NZDUSD-0.12%EURNOK-0.11%CADJPY+0.11%CHFJPY+0.11%GBPCHF+0.10%GBPCAD+0.10%EURCZK+0.09%GBPUSD-0.08%USDNOK+0.08%NZDCHF+0.08%NZDCAD+0.07%USDSGD+0.06%GBPSGD+0.06%USDCOP-0.04%GBPNZD+0.03%USDHKD+0.01%USDTHB0.00%EURDKK0.00%CADCHF0.00%C1-6.05%W1-2.99%XNGUSD+2.94%XPTUSD+2.79%GAGUSD+2.74%XAGUSD+2.74%HG1+2.19%S1-1.79%GAUUSD+1.42%XAUUSD+1.42%COCOA+1.08%COFFEE-0.87%BTCUSD+1.30%ETHUSD+16.31%USDTUSD+0.01%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT+0.03%ZECUSDT+2.77%DOGEUSD+11.60%XMRUSDT-2.03%LINKUSD+12.58%XLMUSD+0.60%BCHUSDT+1.40%LTCUSD+5.93%UNIUSD+3.40%SUIUSD+2.22%HBARUSDT+0.76%TONUSD+24.22%TAOUSDT+2.90%AAVEUSD+2.70%DOTUSDT+10.84%ICPUSDT+4.13%ONDOUSDT+1.62%WLDUSDT+3.49%JUPUSDT+13.29%ARBUSDT+4.81%ATOMUSDT+16.22%STXUSDT+0.16%INJUSDT+2.87%FETUSDT+1.02%PYTHUSDT+3.04%SEIUSDT+0.62%TIAUSDT-4.09%IMXUSDT+0.33%GRTUSDT+2.86%OPUSDT+6.35%IOTAUSDT+0.86%WIFUSDT+2.12%AXSUSDT+1.07%POLUSDT+2.62%FARTCOINUSDT-0.30%EOSUSDT+4.63%DYDXUSDT+4.60%GALAUSDT+1.92%ORDIUSDT+0.65%RONINUSDT+2.73%NOTUSDT+3.72%NVDA-0.40%AAPL-1.61%GOOGL+1.66%MSFT+2.37%AMZN+2.86%TSM-1.61%SPCX+1.21%META+0.72%AVGO+0.73%TSLA+2.34%SKHY-0.25%MU-0.71%BRK-B+0.79%LLY+0.52%AMD-1.67%JPM+0.48%WMT+0.51%V+2.61%XOM+0.54%ASMLa-1.84%JNJ+1.82%INTC-1.47%MA+2.14%0700.HK+3.26%ABBV+1.77%CSCO+2.28%1398.HK-0.92%CVX+0.61%COST-0.50%AMAT-0.02%AP2d-2.02%ORCL+4.61%LRCX-0.20%DELL+0.71%BAC+0.85%KO+0.44%CAT+0.50%PG+0.26%UNH+1.79%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.26%PM+0.08%0857.HK0.00%0939.HK+0.83%NFLX-1.08%MS+1.07%1288.HK-1.52%NZDMXN+1.53%USDMXN+1.47%EURAUD-0.85%AUDJPY+0.65%AUDCHF+0.58%EURUSD-0.55%EURZAR-0.54%USDPLN+0.51%CHFSEK+0.49%AUDCAD+0.48%EURGBP-0.46%USDTRY+0.44%AUDDKK+0.43%GBPAUD-0.43%AUDNZD+0.42%EURNZD-0.42%GBPTRY+0.41%EURCAD-0.37%EURCHF-0.37%GBPZAR-0.36%USDZAR-0.35%EURCNH-0.34%AUDNOK+0.33%USDSEK+0.33%GBPHKD+0.32%EURPLN+0.32%AUDUSD+0.31%AUDSGD+0.31%USDJPY+0.31%GBPMXN-0.28%EURJPY-0.27%CHFNOK+0.24%PLNJPY-0.23%CHFSGD+0.22%SGDJPY+0.22%GBPJPY+0.20%USDCHF+0.19%EURHKD-0.19%NOKJPY+0.19%USDDKK+0.19%NZDJPY+0.19%USDCAD+0.18%USDILS+0.16%USDCNH-0.16%EURSEK+0.14%EURSGD-0.13%NZDSGD+0.12%NZDUSD-0.12%EURNOK-0.11%CADJPY+0.11%CHFJPY+0.11%GBPCHF+0.10%GBPCAD+0.10%EURCZK+0.09%GBPUSD-0.08%USDNOK+0.08%NZDCHF+0.08%NZDCAD+0.07%USDSGD+0.06%GBPSGD+0.06%USDCOP-0.04%GBPNZD+0.03%USDHKD+0.01%USDTHB0.00%EURDKK0.00%CADCHF0.00%C1-6.05%W1-2.99%XNGUSD+2.94%XPTUSD+2.79%GAGUSD+2.74%XAGUSD+2.74%HG1+2.19%S1-1.79%GAUUSD+1.42%XAUUSD+1.42%COCOA+1.08%COFFEE-0.87%BTCUSD+1.30%ETHUSD+16.31%USDTUSD+0.01%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT+0.03%ZECUSDT+2.77%DOGEUSD+11.60%XMRUSDT-2.03%LINKUSD+12.58%XLMUSD+0.60%BCHUSDT+1.40%LTCUSD+5.93%UNIUSD+3.40%SUIUSD+2.22%HBARUSDT+0.76%TONUSD+24.22%TAOUSDT+2.90%AAVEUSD+2.70%DOTUSDT+10.84%ICPUSDT+4.13%ONDOUSDT+1.62%WLDUSDT+3.49%JUPUSDT+13.29%ARBUSDT+4.81%ATOMUSDT+16.22%STXUSDT+0.16%INJUSDT+2.87%FETUSDT+1.02%PYTHUSDT+3.04%SEIUSDT+0.62%TIAUSDT-4.09%IMXUSDT+0.33%GRTUSDT+2.86%OPUSDT+6.35%IOTAUSDT+0.86%WIFUSDT+2.12%AXSUSDT+1.07%POLUSDT+2.62%FARTCOINUSDT-0.30%EOSUSDT+4.63%DYDXUSDT+4.60%GALAUSDT+1.92%ORDIUSDT+0.65%RONINUSDT+2.73%NOTUSDT+3.72%
NA

Natera, Inc. (NTRA)

NASDAQ • Healthcare

$390.79
-$4.76 (-1.2%)
Market open

Last close at October 8, 2026 at 20:00 UTC

Open$387.59
Previous Close$390.79
Day Range$380.39 - $392.96
Avg. Volume (3M)1.9M
Market Cap$57.9B
52 Week Range
$167.99$437.41
Next EarningsIn 27 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$752.7M100%
Gross Profitminus cost of goods$485.1M64%

In plain terms: out of every $100 in revenue, Natera, Inc. currently loses $9.

Fundamentals & Financials

Revenue (TTM)
$2.7B
Net Income (TTM)
-$192.3M
EPS (TTM)
-$1.36
ROA (TTM)
-7.24%
Current Ratio
3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+168.4%Q1 2026$0.35
-3.3%Q2 2026-$0.56
+4.8%Q3 2026-$0.47
Next

Nov 5

in 27 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +4.8%

Natera beat consensus on both revenue and EPS in preliminary second fiscal quarter of 2026 results reported Aug. 6, as revenue rose about 38% to roughly $752.8 million and outpaced the $661.2 million estimate by about 14%, while EPS came in at -$0.47 versus the -$0.49 consensus, a beat of about 5%. Growth was led by the United States, the largest contributor at about $685.6 million, up 39%, while insurance carriers brought in roughly $658.1 million, also up 39%, and laboratory partners added about $28.8 million, up 38%; gross margin held at 64.5% even as operating margin was -10.1% on operating income of negative about $75.8 million. Net income improved 34% to a loss of about $67.0 million from $100.9 million a year earlier, EPS was up 37% from -$0.74, and operating cash flow was about $40.2 million.

Next report — what to expect

Natera, Inc. (NTRA) reports earnings on November 5, 2026. Wall Street is looking for EPS of -$0.24 on revenue of $707.8 million. For trailing context, revenue grew +37.7% year over year last quarter. Natera has beaten EPS in 4 of its 8 most recent quarters, making guidance and testing-volume commentary key watch items.

View full earnings history

About Natera, Inc.

Natera, Inc. (NASDAQ: NTRA) develops genetic testing and molecular monitoring products for healthcare, operating in diagnostics and research, with $2.3 billion in revenue in FY2025. Its menu spans reproductive health, oncology, and transplant testing, pairing laboratory-developed assays with direct sales and partner distribution on a global basis.

Name
Natera, Inc.
CEO
Steven Leonard Chapman
Website
www.natera.com
Industry
Healthcare
Year Founded
2003
Employees
6,138

Today's Snapshot

AI-generated

The session opened with NTRA 0.5% higher at 392.90, in line with a firmer sector. Natera received breakthrough-device status from the FDA, the U.S. regulator, for a blood test detecting multiple cancers early.

Trading Volume

Below 10d avg (2.0M)

303.3K

vs S&P 500 Today

Outperforming Market

+1.40%

Updated: October 9, 2026 at 14:57 UTC

NTRA Headlines

Citi Resets Life Sciences And MedTech Views

March 11, 2026

5 min read
View All News

Technical Indicators

4 Buy3 Neutral1 Sell
NTRA reads as a buy in a strong uptrend, with ADX signaling robust directional strength and multiple medium- and long-term moving averages well below the current level, even though the nearest short-term averages are slightly higher. Momentum indicators include a positive MACD and neutral RSI, while the classic pivot lies below price, offering a nearby reference for support. Volatility is moderate and on-balance volume currently shows some divergence, tempering the signal. Technical takeaway: bias is Buy, reflecting strong trend support from medium-to-long-term averages.
All signals
  • EMA (5 indicators)$271.57 - $399.47
    Buy
  • RSI (14)59.53
    Neutral
  • Stochastic %K (14, 3, 3)42.18
    Neutral
  • MACD Level (12, 26)17.92
    Neutral

Peers & Related Assets

VCYTVeracyte, Inc.
$43.6+1.0%
WGSGeneDx Holdings Corp.
$67.73-1.2%
FLGTFulgent Genetics, Inc.
$20.82+1.2%
MYGNMyriad Genetics, Inc.
$4.2-1.9%
BLLNBillionToOne, Inc.
PSNLPersonalis, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.